Soleno Therapeutics (SLNO) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.83
-1.34
-0.85
-0.37

Details

Expected EPS
-0.97375
Actual EPS
-1.27
Surprise EPS
-0.3
Surprise Percent
+30.42%

Description

Soleno Therapeutics (SLNO) has reported earnings of -1.27 per share for Q1 2025.

0 Comments

Share your thoughts